Accretion

M&A

Turkish: Artırıcı Etki

Short definition

Accretion is the deal lifting EPS (or FCF per share) above the stand-alone. It is not a proxy for value creation; accounting earnings can skip cash and the ROIC hurdle.

Detailed explanation

Cash plus cheap debt on a low-multiple target lifts EPS — even if WACC and ROIC worsen. A share issue does the reverse and dilutes.

Amortisation, inventory and synergy timing break year-one EPS. The market can cheer an accretive deal and punish value.

Why it matters for the CFO

A board can pass an expensive deal because “EPS will rise”. The CFO’s job is ROIC–WACC and the cash bridge on the same slide.

How it is calculated

Artırıcı ≈ birleşme sonrası EPS > duran EPS (finansman ve sinerji sonrası)

Variables in the formula

  • EPS: earnings per share

How to read it

Accretive plus ROIC < WACC is an accounting win and a value loss. Conversely, temporary dilution should not kill a valuable job.

Related calculators

Güven Sayılgan’s writing on this topic

Read these first

What to learn next

  1. Dilution
  2. Purchase Price
  3. Synergy
  4. Leveraged Buyout (LBO)
  5. Weighted Average Cost of Capital (WACC)

Definitions are educational. They are not investment, credit or tax advice.